Membership
Tour
Register
Log in
HETEROCYCLIC COMPOUNDS
Follow
Industry
CPC
C07D
Parent Industries
C
CHEMISTRY METALLURGY
C07
Organic chemistry
Current Industry
C07D
HETEROCYCLIC COMPOUNDS
Sub Industries
C07D201/00
Preparation, separation, purification or stabilisation of unsubstituted lactams
C07D203/00
Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
C07D205/00
Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
C07D207/00
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D209/00
Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
C07D211/00
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
C07D213/00
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
C07D215/00
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
C07D217/00
Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
C07D219/00
Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
C07D221/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
C07D223/00
Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
C07D225/00
Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
C07D227/00
Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
C07D229/00
Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms
C07D231/00
Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
C07D233/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
C07D235/00
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
C07D237/00
Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
C07D239/00
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
C07D241/00
Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
C07D243/00
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
C07D245/00
Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
C07D247/00
Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups C07D229/00 - C07D245/00
C07D249/00
Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
C07D251/00
Heterocyclic compounds containing 1,3,5-triazine rings
C07D253/00
Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
C07D255/00
Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
C07D257/00
Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
C07D259/00
Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
C07D261/00
Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
C07D263/00
Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
C07D265/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D267/00
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
C07D269/00
Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups C07D261/00 - C07D267/00
C07D271/00
Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
C07D273/00
Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
C07D275/00
Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
C07D277/00
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
C07D279/00
Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D281/00
Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
C07D283/00
Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups C07D275/00 - C07D281/00
C07D285/00
Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
C07D291/00
Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
C07D293/00
Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
C07D295/00
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicylo [3.2.2.] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
C07D301/00
Preparation of oxiranes
C07D303/00
Compounds containing three-membered rings having one oxygen atom as the only ring heteroatom
C07D305/00
Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atom
C07D307/00
Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
C07D309/00
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
C07D311/00
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
C07D313/00
Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
C07D315/00
Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
C07D317/00
Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
C07D319/00
Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
C07D321/00
Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
C07D323/00
Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
C07D325/00
Heterocyclic compounds containing rings having oxygen as the only ring hetero atoms according to more than one of the main groups C07D303/00 - C07D323/00
C07D327/00
Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
C07D329/00
Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms
C07D331/00
Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
C07D333/00
Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
C07D335/00
Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
C07D337/00
Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
C07D339/00
Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
C07D341/00
Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
C07D343/00
Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms
C07D345/00
Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms
C07D347/00
Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms
C07D401/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
C07D403/00
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
C07D405/00
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
C07D407/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
C07D409/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
C07D411/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D413/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D415/00
Heterocyclic compounds containing the thiamine skeleton
C07D417/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
C07D419/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
C07D421/00
Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms
C07D451/00
Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems
C07D453/00
Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems
C07D455/00
Heterocyclic compounds containing quinolizine ring systems
C07D457/00
Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems
C07D459/00
Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems
C07D461/00
Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems
C07D463/00
Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D471/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
C07D473/00
Heterocyclic compounds containing purine ring systems
C07D475/00
Heterocyclic compounds containing pteridine ring systems
C07D477/00
Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , carbapenicillins, thienamycins Such ring systems being further condensed
C07D487/00
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
C07D489/00
Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems
C07D491/00
Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
C07D493/00
Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
C07D495/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
C07D497/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
C07D498/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
C07D499/00
Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:
C07D501/00
Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D503/00
Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:
C07D505/00
Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:
C07D507/00
Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups C07D463/00, C07D477/00 or C07D499/00 - C07D505/00 Such ring systems being further condensed
C07D513/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D515/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
C07D517/00
Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium or halogen atoms as ring hetero atoms
C07D519/00
Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
C07D521/00
Heterocyclic compounds containing unspecified hetero rings
Industries
Overview
Organizations
People
Information
Impact
Patents Grants
last 30 patents
Information
Patent Grant
2-amino-N-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds...
Patent number
12,247,004
Issue date
Mar 11, 2025
Oxford Drug Design Limited
Grace Edmund
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Crosslinkers for mass spectrometric identification and quantitation...
Patent number
12,247,009
Issue date
Mar 11, 2025
Institute for Systems Biology
Jie Luo
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
2,3-diaryl-1,3-thiazepan-4-ones compounds and methods for making
Patent number
12,247,014
Issue date
Mar 11, 2025
The Penn State Research Foundation
Lee J. Silverberg
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Aryl-n-aryl derivatives for treating a RNA virus infection
Patent number
12,247,018
Issue date
Mar 11, 2025
ABIVAX
Didier Scherrer
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Articles comprising indolenaphthopyrans
Patent number
12,247,035
Issue date
Mar 11, 2025
Transitions Optical, Ltd.
Ryan Stayshich
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Organic electroluminescence element and electronic device
Patent number
12,250,883
Issue date
Mar 11, 2025
Idemitsu Kosan Co., Ltd.
Takushi Shiomi
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Grant
Cyclobutyl pyrazolopyrimidine PDE9 inhibitors
Patent number
12,247,031
Issue date
Mar 11, 2025
Merck Sharp & Dohme LLC
Ashok Arasappan
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinases
Patent number
12,247,032
Issue date
Mar 11, 2025
Genentech, Inc.
Mark Edward Zak
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compositions and methods for treating neurodegenerative, myodegener...
Patent number
12,246,009
Issue date
Mar 11, 2025
Georgetown University
Christian Wolf
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2...
Patent number
12,246,196
Issue date
Mar 11, 2025
Daiichi Sankyo Company, Limited
Narihiro Toda
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Heterocyclic compound and organic light emitting device comprising...
Patent number
12,250,879
Issue date
Mar 11, 2025
LG Chem, Ltd.
Su Jin Han
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Deuterium-containing compound, and organic light-emitting device co...
Patent number
12,250,882
Issue date
Mar 11, 2025
LG Chem, Ltd.
Hongsik Yoon
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Grant
Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitors
Patent number
12,247,033
Issue date
Mar 11, 2025
GlaxoSmithKline Intellectual Property Development Limited
Adam K. Charnley
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Pyrido[3,2-d]pyrimidine compounds as immunomodulators
Patent number
12,247,038
Issue date
Mar 11, 2025
Incyte Corporation
Jingwei Li
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
MAP4K4 inhibitors
Patent number
12,247,045
Issue date
Mar 11, 2025
Imperial College Innovations Limited
Michael Schneider
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Fluoroelastomer composition
Patent number
12,247,111
Issue date
Mar 11, 2025
Solvay Specialty Polymers Italy S.p.A.
Stefano Bossolo
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as in...
Patent number
12,247,015
Issue date
Mar 11, 2025
SOLENT THERAPEUTICS, LLC
Simone Bigi
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Epoxidation process with increased cycle water absorption
Patent number
12,247,016
Issue date
Mar 11, 2025
Scientific Design Company, Inc.
Mansoor Husain
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Inhibitors of dihydroceramide desaturase for treating disease
Patent number
12,247,019
Issue date
Mar 11, 2025
Centaurus Therapeutics
Donna L. Romero
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Compound for organic electronic element, organic electronic element...
Patent number
12,247,023
Issue date
Mar 11, 2025
DUK SAN NEOLUX CO., LTD.
Eun Min Kim
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Process for preparing aficamten
Patent number
12,247,024
Issue date
Mar 11, 2025
Cytokinetics, Inc.
Denise Andersen
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Processes for preparation of soluble guanylate cyclase stimulators
Patent number
12,247,025
Issue date
Mar 11, 2025
Cyclerion Therapeutics, Inc.
Song Xue
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Heterocyclic compounds as immunomodulators
Patent number
12,247,026
Issue date
Mar 11, 2025
Incyte Corporation
Liangxing Wu
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
P2X7 modulators
Patent number
12,247,027
Issue date
Mar 11, 2025
JANSSEN PHARMACEUTICA NV
Manuel Jesus Alcazar Vaca
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Azabicyclo and diazepine derivatives
Patent number
12,247,028
Issue date
Mar 11, 2025
Alcon Inc.
David Ellis
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Fabrication of luminescent quantum dot thiol-yne nanocomposites wit...
Patent number
12,247,152
Issue date
Mar 11, 2025
The Government of the United States of America, as represented by the Secreta...
Darryl A. Boyd
C07 - ORGANIC CHEMISTRY
Information
Patent Grant
Light emitting device and production method thereof, and compositio...
Patent number
12,250,870
Issue date
Mar 11, 2025
Sumitomo Chemical Company, Limited
Toshiaki Sasada
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Grant
Crystalline form of deuruxolitinib phosphate
Patent number
12,247,034
Issue date
Mar 11, 2025
Sun Pharmaceutical Industries, Inc.
Sean Wiedemann
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]tr...
Patent number
12,247,037
Issue date
Mar 11, 2025
NEUMORA THERAPEUTICS, INC.
Gary Brandt
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information
Patent Grant
Photo-coupled synergistically crosslinked hydrogel material and its...
Patent number
12,247,089
Issue date
Mar 11, 2025
Zhongshan Guanghe Medical Technology Co., Ltd.
Linyong Zhu
B33 - ADDITIVE MANUFACTURING TECHNOLOGY
Patents Applications
last 30 patents
Information
Patent Application
ANTIBACTERIAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS O...
Publication number
20250082606
Publication date
Mar 13, 2025
Miralogx LLC
Jonnie R. Williams
C07 - ORGANIC CHEMISTRY
Information
Patent Application
CONJUGATES OF CHEMOTHERAPY AGENTS AND TISSUE-BINDING SMALL MOLECULE...
Publication number
20250082657
Publication date
Mar 13, 2025
CanWell Biotech Limited
NINGHUI YU
C07 - ORGANIC CHEMISTRY
Information
Patent Application
FUSED CYCLOOCTYNE COMPOUNDS AND THEIR USE IN METAL-FREE CLICK REACT...
Publication number
20250084022
Publication date
Mar 13, 2025
SYNAFFIX B.V.
Floris Louis van Delft
G01 - MEASURING TESTING
Information
Patent Application
NOVEL AROMATIC MOLECULES
Publication number
20250084023
Publication date
Mar 13, 2025
XENIOPRO GmbH
Viktoria REINMÜLLER
C07 - ORGANIC CHEMISTRY
Information
Patent Application
NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, PREPARATION METHOD THE...
Publication number
20250084026
Publication date
Mar 13, 2025
ILDONG PHARMACEUTICAL CO., LTD.
Hong Chul Yoon
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PPARG INVERSE AGONISTS AND USES THEREOF
Publication number
20250084038
Publication date
Mar 13, 2025
Flare Therapeutics Inc.
Jonathan E. Wilson
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
Publication number
20250084048
Publication date
Mar 13, 2025
Relay Therapeutics, Inc.
Alessandro BOEZIO
C07 - ORGANIC CHEMISTRY
Information
Patent Application
3-(2-(4-METHOXYPYRIDIN-3-YL)-4,5-DIPHENYL-1H-IMIDAZOL-1-YL)-N,N-DIM...
Publication number
20250084052
Publication date
Mar 13, 2025
King Faisal University
HANY MOHAMED ABD EL-LATEEF AHMED
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SUBSTITUTED OXOISOINDOLINYL PIPERIDINE-2,6-DIONE COMPOUNDS
Publication number
20250084056
Publication date
Mar 13, 2025
Bristol-Myers Squibb Company
DANIEL FERRANTE
C07 - ORGANIC CHEMISTRY
Information
Patent Application
GERALEXIN AND USES THEREOF FOR THE TREATMENT OF RETINAL DEGENERATIV...
Publication number
20250084069
Publication date
Mar 13, 2025
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Thierry LEVEILLARD
C07 - ORGANIC CHEMISTRY
Information
Patent Application
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH...
Publication number
20250084071
Publication date
Mar 13, 2025
Novartis Pharma AG
Shankar Venkatraman
C07 - ORGANIC CHEMISTRY
Information
Patent Application
HETEROCYCLIC KINASE INHIBITORS AND USES THEREOF
Publication number
20250084076
Publication date
Mar 13, 2025
iOmx Therapeutics AG
Peter SENNHENN
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
Publication number
20250084088
Publication date
Mar 13, 2025
GILEAD SCIENCES, INC.
Deeba Ensan
C07 - ORGANIC CHEMISTRY
Information
Patent Application
Unique and Selective Targeting of CDK Activity in Aggressive Carcin...
Publication number
20250084089
Publication date
Mar 13, 2025
UNIVERSITY OF WINDSOR
John F. Trant
G01 - MEASURING TESTING
Information
Patent Application
SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY
Publication number
20250084090
Publication date
Mar 13, 2025
Sumitomo Pharma Co., Ltd.
Hidefumi YOSHINAGA
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ANNULATED PYRIDAZINE COMPOUND
Publication number
20250084092
Publication date
Mar 13, 2025
Nico Therapeutics, Inc.
Yusuke Inagaki
C07 - ORGANIC CHEMISTRY
Information
Patent Application
SPIROCYCLIC INHIBITORS OF APOL1 AND METHODS OF USING SAME
Publication number
20250084094
Publication date
Mar 13, 2025
Timothy J. Senter
C07 - ORGANIC CHEMISTRY
Information
Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
Publication number
20250084104
Publication date
Mar 13, 2025
INCYTE CORPORATION
Liangxing Wu
C07 - ORGANIC CHEMISTRY
Information
Patent Application
ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
Publication number
20250084107
Publication date
Mar 13, 2025
UNIVERSAL DISPLAY CORPORATION
Tyler FLEETHAM
C07 - ORGANIC CHEMISTRY
Information
Patent Application
COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
Publication number
20250089561
Publication date
Mar 13, 2025
Idemitsu Kosan Co.,Ltd
Yu KUDO
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Application
MALATE SALT OF N-(4-{[6,7-BIS(METHYLOXY) QUINOLIN-4-YL]OXY}PHENYL)-...
Publication number
20250084037
Publication date
Mar 13, 2025
Exelixis, Inc.
Adrian St. Clair Brown
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PROTOPORPHYRINOGEN OXIDASE INHIBITORS
Publication number
20250084044
Publication date
Mar 13, 2025
Enko Chem, Inc.
Neville John ANTHONY
A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information
Patent Application
COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE
Publication number
20250084047
Publication date
Mar 13, 2025
Idemitsu Kosan Co., Ltd.
Yu KUDO
C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information
Patent Application
glycerylphosphorylethanolamine (GPE) compound and lipid nanoparticl...
Publication number
20250084051
Publication date
Mar 13, 2025
Shandong Academy of Pharmaceutical Sciences
Song XUE
C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information
Patent Application
SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION
Publication number
20250084054
Publication date
Mar 13, 2025
Janna Therapeutics Inc
Dean G. Brown
C07 - ORGANIC CHEMISTRY
Information
Patent Application
DIHYDROQUINOLINONES FOR MEDICAL TREATMENT
Publication number
20250084055
Publication date
Mar 13, 2025
C4 Therapeutics, Inc.
Roger Norcross
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PROCESS FOR UNPROTECTED ASYMMETRIC PREPARATION OF NICOTINE
Publication number
20250084057
Publication date
Mar 13, 2025
SHENZHEN CATALYS TECHNOLOGY CO., LTD.
Qiwei LANG
B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information
Patent Application
BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS
Publication number
20250084063
Publication date
Mar 13, 2025
INCYTE CORPORATION
Oleg Vechorkin
C07 - ORGANIC CHEMISTRY
Information
Patent Application
2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS
Publication number
20250084064
Publication date
Mar 13, 2025
Merck Sharp & Dohme LLC
Ashok Arasappan
C07 - ORGANIC CHEMISTRY
Information
Patent Application
PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF
Publication number
20250084067
Publication date
Mar 13, 2025
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD
Yinsheng ZHANG
C07 - ORGANIC CHEMISTRY